Onconetix (ONCO) Competitors $0.35 -0.01 (-3.64%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends ONCO vs. AIM, TXMD, HCWB, MRNS, PMCB, SLGL, WENA, IPA, IMNN, and AWHShould you be buying Onconetix stock or one of its competitors? The main competitors of Onconetix include AIM ImmunoTech (AIM), TherapeuticsMD (TXMD), HCW Biologics (HCWB), Marinus Pharmaceuticals (MRNS), PharmaCyte Biotech (PMCB), Sol-Gel Technologies (SLGL), ANEW Medical (WENA), ImmunoPrecise Antibodies (IPA), Imunon (IMNN), and Aspira Women's Health (AWH). These companies are all part of the "pharmaceutical products" industry. Onconetix vs. AIM ImmunoTech TherapeuticsMD HCW Biologics Marinus Pharmaceuticals PharmaCyte Biotech Sol-Gel Technologies ANEW Medical ImmunoPrecise Antibodies Imunon Aspira Women's Health AIM ImmunoTech (NYSE:AIM) and Onconetix (NASDAQ:ONCO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation, risk and community ranking. Do analysts prefer AIM or ONCO? AIM ImmunoTech presently has a consensus price target of $2.75, suggesting a potential upside of 1,347.37%. Given AIM ImmunoTech's stronger consensus rating and higher probable upside, analysts clearly believe AIM ImmunoTech is more favorable than Onconetix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AIM ImmunoTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Onconetix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, AIM or ONCO? AIM ImmunoTech has a beta of -0.36, meaning that its share price is 136% less volatile than the S&P 500. Comparatively, Onconetix has a beta of 3.25, meaning that its share price is 225% more volatile than the S&P 500. Does the MarketBeat Community favor AIM or ONCO? AIM ImmunoTech received 59 more outperform votes than Onconetix when rated by MarketBeat users. CompanyUnderperformOutperformAIM ImmunoTechOutperform Votes5983.10% Underperform Votes1216.90%OnconetixN/AN/A Do insiders & institutionals believe in AIM or ONCO? 12.0% of AIM ImmunoTech shares are owned by institutional investors. Comparatively, 23.9% of Onconetix shares are owned by institutional investors. 0.0% of AIM ImmunoTech shares are owned by company insiders. Comparatively, 11.4% of Onconetix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer AIM or ONCO? In the previous week, AIM ImmunoTech had 9 more articles in the media than Onconetix. MarketBeat recorded 9 mentions for AIM ImmunoTech and 0 mentions for Onconetix. AIM ImmunoTech's average media sentiment score of 0.07 beat Onconetix's score of 0.00 indicating that AIM ImmunoTech is being referred to more favorably in the media. Company Overall Sentiment AIM ImmunoTech Neutral Onconetix Neutral Is AIM or ONCO more profitable? Onconetix has a net margin of -2,758.89% compared to AIM ImmunoTech's net margin of -12,594.21%. AIM ImmunoTech's return on equity of -421.73% beat Onconetix's return on equity.Company Net Margins Return on Equity Return on Assets AIM ImmunoTech-12,594.21% -421.73% -147.54% Onconetix -2,758.89%-1,472.15%-48.09% Which has stronger earnings & valuation, AIM or ONCO? AIM ImmunoTech has higher earnings, but lower revenue than Onconetix. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAIM ImmunoTech$190K63.78-$28.96M-$0.47-0.40Onconetix$1.87M1.54-$37.41MN/AN/A SummaryAIM ImmunoTech beats Onconetix on 9 of the 15 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Onconetix News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONCO vs. The Competition Export to ExcelMetricOnconetixPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.88M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E RatioN/A10.5989.9717.17Price / Sales1.54196.061,117.23117.03Price / CashN/A57.1643.0437.86Price / Book0.125.094.784.78Net Income-$37.41M$151.83M$120.31M$225.60M7 Day Performance-13.71%-2.13%-1.92%-1.23%1 Month Performance-68.17%-4.55%13.64%0.46%1 Year PerformanceN/A8.87%28.32%15.25% Onconetix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCOOnconetix0.1436 of 5 stars$0.35-3.6%N/AN/A$2.88M$1.87M0.0012AIMAIM ImmunoTech2.3673 of 5 stars$0.22-1.6%$2.75+1,176.7%-60.4%$13.74M$190,000.00-0.4720TXMDTherapeuticsMD0.4365 of 5 stars$1.18-3.4%N/A-53.8%$13.59M$1.30M0.00420Analyst ForecastGap UpHCWBHCW Biologics0.406 of 5 stars$0.36-0.1%N/A-60.4%$13.48M$3.50M-0.3640Gap DownMRNSMarinus Pharmaceuticals4.3176 of 5 stars$0.24-8.6%$4.79+1,893.2%-97.6%$13.25M$31.47M-0.10110Analyst ForecastNews CoveragePMCBPharmaCyte Biotech0.4217 of 5 stars$1.67-2.9%N/A-24.8%$12.83MN/A2.612Earnings ReportSLGLSol-Gel Technologies2.4245 of 5 stars$0.45-5.3%$5.00+1,000.6%-66.5%$12.66M$1.55M-1.3650WENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpIPAImmunoPrecise Antibodies2.9227 of 5 stars$0.42+4.4%$5.00+1,087.4%-69.5%$12.14M$24.07M-0.5280News CoverageIMNNImunon2.3546 of 5 stars$0.84-1.1%$20.50+2,355.1%+9.2%$12.11M$500,000.00-0.4533Analyst ForecastNews CoverageGap UpAWHAspira Women's Health1.218 of 5 stars$0.71-5.2%$4.40+519.1%-69.7%$11.85M$9.15M-0.62110Analyst Forecast Related Companies and Tools Related Companies AIM Alternatives TXMD Alternatives HCWB Alternatives MRNS Alternatives PMCB Alternatives SLGL Alternatives WENA Alternatives IPA Alternatives IMNN Alternatives AWH Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ONCO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconetix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Onconetix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONCO Stock Alerts